A History of Success,
and Foundation for the Future
BioCina’s Roots Run Deep
Adelaide
Perth
Adelaide: Bresagen Ltd. spun out of the University of Adelaide
1982Technology Park Facility Opening
Technology Park Facility opened by the Delta West company in Perth, Australia.
1987Blow-Fill-Seal Introduction
Blow-Fill-Seal packaging technology first introduced to the site
1988High Potency Oncology Packaging Introduction
High potency Oncology packaging technology first introduced to the site
1989Delta West acquired by Upjohn
Delta West was acquired by Upjohn Company, later renamed Pharmacia. Site continued to specialize in Blow-Fill-Seal and Oncology packaging.
1991Launch of First Cytotoxic Product
Launched first oncology products for the US market
1995Adelaide: Original GMP facility was built
Perth: Pfizer acquires Pharmacia
Pfizer acquired Pharmacia. Technology Park Facility in Perth, Australia became Pfizer’s center of excellence for Oncology and Blow-Fill-Seal products.
2003Adelaide: Facility licensed by the Australian TGA
2004Adelaide: Site acquired by Hospira
Perth: Pfizer’s Investment Program
Pfizer began an extensive investment program adding significant capabilities to the site including adding a Restricted Access Barrier System (RABS) and upgrading of Oncology and Specialty production line systems
2006Adelaide: Installation of 750 L fermenter and 2,900 L refold tank
2009Perth: Rommelag Commissioned
New State-of-the-art Rommelag Blow-Fill-Seal production line commissioned
2012Adelaide: New large scale purification equipment
2012-2013Adelaide: Hospira Technology Team of the Year (Pharma/Biologics)
$21M Facility upgrade approved
2014Adelaide: Pfizer acquires Hospira
Adelaide: Pfizer President’s Award
2015Adelaide: Facility upgrade completed
2016Adelaide: GMP warehouse and QC laboratory upgrades completed
2017Adelaide: Pfizer President’s Award
Perth: New Vial Line Commissioned
New Vial line for terminally sterilised vials commissioned
2018Adelaide: US-FDA Pre-approval and GMP inspection
Adelaide: Pfizer – Bridgewest agreement for sale of Adelaide site
2020Adelaide: BioCina Established CDMO Bridgewest Australia Biotech dba BioCina
Perth: Pfizer Safety Award
Pfizer Safety & Sustainability Star Award
2021Perth: Establishment of NovaCina
NovaCina established by the Bridgewest Group, a premiere privately held investment group that specializes in the life-science and technology sectors
Perth: Pfizer Bold Move Award
Pfizer Bold Move award prior to NovaCina being established
2023Merger of BioCina with NovaCina
Creating End-to-End Global Biologics DS and Multimodality DP CDMO
2025Our US FDA, EMA, and TGA approved site has a has a 40+ year history in successful development and manufacturing delivery. Through the journey from its origins as Bresagen, to Pfizer, to BioCina now, our people have personally walked the path from research and development to commercial manufacturing and are uniquely suited to guide your biologic from concept to approval. With the microbial, plasmid DNA, and mRNA modalities, BioCina has worked on over the past 15 years 60 different products with more than 30 global partners.
1982
Bresagen Ltd. spun out of the University of Adelaide
Original GMP facility was built
2003
2004
Facility licensed by the Australian TGA
Site acquired by Hospira
2006
2009
Installation of 750 L fermenter and 2,900 L refold tank
New large scale purification equipment
2012-13
2014
Hospira Technology Team of the Year (Pharma/Biologics)
$21M Facility upgrade approved
Pfizer acquires Hospira
Pfizer President’s Award
2015
2016
Facility upgrade completed
GMP warehouse and QC laboratory upgrades completed
2017
2018
Pfizer President’s Award
US-FDA Pre-approval and GMP inspection
Pfizer – Bridgewest agreement for sale of Adelaide site
2020
2021
BioCina Established CDMO Bridgewest Australia Biotech dba BioCina
Merger with Novacina
Creating End-to-End Global Biologics DS and Multimodality DP CDMO